| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 44,751 | 47,224 | 48,048 | 53,535 | | Cost of Revenue | 32,910 | 35,645 | 37,107 | 40,263 | | | Gross Profit | 11,841 | 11,579 | 10,941 | 13,272 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,721 | 11,015 | 11,007 | 12,212 | | Non Recurring |
-
|
-
|
-
| 43,315 | | Others | 424 | 405 | 383 | 528 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 696 | 159 | (449) | (42,783) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (9,724) | 54 | 9,740 | (125) | | Earnings Before Interest And Taxes | 706 | 213 | 9,291 | (42,908) | | Interest Expense | (23) | 3 | 20 | 53 | | Income Before Tax | 729 | 210 | 9,271 | (42,961) | | Income Tax Expense | 293 | (36) | 3,718 | (3,821) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 436 | 246 | 5,553 | (39,140) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 436 | 246 | 5,553 | (39,140) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $436 | $246 | $5,553 | ($39,140) |
|
0.31% Nasdaq 0.00%
Income Statement
